| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2004 | EP1434575A1 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites |
| 07/07/2004 | EP1434574A2 Tolterodine metabolites |
| 07/07/2004 | EP1434573A2 Irrigation solution and method for inhibition of pain and inflammation |
| 07/07/2004 | EP1434572A2 Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principles |
| 07/07/2004 | EP1434570A1 Pharmaceutical formulations for the controlled release of 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline |
| 07/07/2004 | EP1434568A1 Extended release pharmaceutical composition containing metformin |
| 07/07/2004 | EP1434567A1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 07/07/2004 | EP1434565A2 Use of ganoderic acids as cosmetic agents and for treating or preventing skin disorder and corresponding composition |
| 07/07/2004 | EP1434563A1 Methods for the treatment of hyperpigmentation of skin |
| 07/07/2004 | EP1434562A1 Cosmetic and dermatological stick |
| 07/07/2004 | EP1434561A1 Skin care compositions containing peptide copper complexes and retinol, retinol derivatives, or a mixture thereof |
| 07/07/2004 | EP1434556A1 Cosmetic and/or pharmaceutical preparations |
| 07/07/2004 | EP1434485A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 07/07/2004 | EP1401431A4 Human growth hormone antagonists |
| 07/07/2004 | EP1377280A4 Bulking agents as satiety agents |
| 07/07/2004 | EP1354055A4 Neocentromere-based mini-chromosomes or artificial chromosomes |
| 07/07/2004 | EP1318791B1 Pharmaceutical semi-solid composition of isotretinoin |
| 07/07/2004 | EP1278523B1 Combination of progesterone and mifepristone for cancer therapy |
| 07/07/2004 | EP1242404B1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 07/07/2004 | EP1235827B1 Imidazo-pyridine derivatives as ligands for gaba receptors |
| 07/07/2004 | EP1230222B1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/07/2004 | EP1218359B1 Piperazine compounds as tachykinins antagonists |
| 07/07/2004 | EP1196195A4 Nasogastric enteral formulations |
| 07/07/2004 | EP1156801B1 SUBSTITUTED BENZO(1,2-b:5,4-b')DIPYRAN-4-AMINES AS CCR5 MODULATORS |
| 07/07/2004 | EP1087971B1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 07/07/2004 | EP1082093B1 Anti-germ attachment - composition |
| 07/07/2004 | EP1073435B1 Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 07/07/2004 | EP1073431B1 Use of nmda antagonists for treatment of irritable bowel syndrome |
| 07/07/2004 | EP1071670B1 Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 07/07/2004 | EP1047694B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 07/07/2004 | EP1038525B1 Stabilized composition of tetrahydropyrrolo [1,2-a] pyrazine-4-spiro-3'-pyrrolidine |
| 07/07/2004 | EP1012136B1 Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists |
| 07/07/2004 | EP1006794A4 A method for treating or preventing alzheimer's disease |
| 07/07/2004 | EP0981520B1 Efficient enantioselective addition reaction using an organozinc reagent |
| 07/07/2004 | EP0967978B1 Combined preparation of 2-methylthiazolidine-2,4-dicarboxylic acid and paracetamol |
| 07/07/2004 | EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/07/2004 | EP0928198B1 Vaccine composition comprising outer membrane protein fragments of bordetella pertussis |
| 07/07/2004 | EP0918519B1 Therapeutic treatment for vegf related occular diseases |
| 07/07/2004 | EP0907373B1 Use of synergistic compositions of il-12 and ifn-alpha for the treatment of infectious diseases |
| 07/07/2004 | EP0825851B1 Emulsion suitable for administering a poorly water-soluble photosensitizing compound and use thereof |
| 07/07/2004 | EP0779074B1 Protective agent for organ or tissue |
| 07/07/2004 | EP0759749B1 Anti-acne compositions |
| 07/07/2004 | CN1511189A Process for preparing vegetable oil fractions rich in non-tocolic high-melting, unsaponifiable matter |
| 07/07/2004 | CN1511161A Novel tricyclic dikydro-quinolin derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/07/2004 | CN1511159A Nitrogen-based camptothecin derivatives |
| 07/07/2004 | CN1511158A Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/07/2004 | CN1511157A Novel pyrrole derivatives as pharmaceutical agents |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511154A Quinuclidines-substituted-multi-cycli-heteroaryls for treatment of disease |
| 07/07/2004 | CN1511153A 苯并咪唑衍生物 Benzimidazole derivatives |
| 07/07/2004 | CN1511152A N-formyl hydroxylamine compounds as PDF inhibitor |
| 07/07/2004 | CN1511149A 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1511044A Elogated and multiple spacers in activatible prodrugs |
| 07/07/2004 | CN1511043A Pregabalin lactose conjugates |
| 07/07/2004 | CN1511042A PD 4 inhibitor and anti-cholinergic agent in combination for treating obstructive airways diseases |
| 07/07/2004 | CN1511039A Method for lowering serum glucose |
| 07/07/2004 | CN1511038A Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 07/07/2004 | CN1511037A Nonintestinal estramustine phosphate and albumin preparations |
| 07/07/2004 | CN1511036A Combination comprising signal transduction inhibitor and epothilone derivative |
| 07/07/2004 | CN1511035A Gatifloxacin pentahydrate |
| 07/07/2004 | CN1511034A Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity |
| 07/07/2004 | CN1511033A Liquid drug preparations |
| 07/07/2004 | CN1511032A Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 07/07/2004 | CN1511031A Solid pharmaceutical formulations comprising modafinil |
| 07/07/2004 | CN1511030A Abuse resistant pharmaceutical composition containing capsaicin |
| 07/07/2004 | CN1511029A Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-D] pyrimidine for treatment of pain |
| 07/07/2004 | CN1511026A Granular preparations of gaboxadol |
| 07/07/2004 | CN1510147A Determination of alpha-N-acetamino galactosidase activity |
| 07/07/2004 | CN1510144A Establishment and use of hfg 12 prothrombin double chain RNA and oligonucleotide |
| 07/07/2004 | CN1510137A Gene identification |
| 07/07/2004 | CN1510130A Attenuated cattle viral diarrhoea virus |
| 07/07/2004 | CN1510038A Oligose in cryptococcus polysaccharose and its use |
| 07/07/2004 | CN1510037A Cornel extractive, extracting method and use for preparing medicine and health food |
| 07/07/2004 | CN1510034A Indazole compound, preparing method thereof and medicine composition containing the same |
| 07/07/2004 | CN1510032A Oxazolidone compound, preparing method and use thereof |
| 07/07/2004 | CN1509752A Medicine for treating skin chap, and preparing method thereof |
| 07/07/2004 | CN1509723A Compound phenformin |
| 07/07/2004 | CN1509722A Cordyceps sinensis polysaccharide emulsion and preparing method thereof |
| 07/07/2004 | CN1509721A Composition containing plant estrogen and amino glucose against bone retrograde affection and preparation |
| 07/07/2004 | CN1509720A Progesterone capsule and preparing method thereof |
| 07/07/2004 | CN1509719A Medicine for treating climacteric syndrome |
| 07/07/2004 | CN1509718A Medicine releasing composition for improving steroid compound stability |
| 07/07/2004 | CN1509717A Skin penetrating paste containing ligustrazine free alkali and its preparation |
| 07/07/2004 | CN1509716A Application of oxidative matridine in antipruritic medicine |
| 07/07/2004 | CN1509715A Rifaximin drop |
| 07/07/2004 | CN1509714A Rifaximin spray |
| 07/07/2004 | CN1509713A Indole derivative use as 5HT1 antagonist agent |
| 07/07/2004 | CN1509712A Drugs with extracts of racemic plant as estrogens with organic selectivity and without organotropism of womb |
| 07/07/2004 | CN1509711A Fenfibrate masticatory and its preparation |
| 07/07/2004 | CN1156489C Method for preparing erythromycin derivative |
| 07/07/2004 | CN1156488C Derivative of micronomycine and its preparing process and medical application |
| 07/07/2004 | CN1156480C Water soluble SDZ-RAD esters, its preparation method, use and composition thereof |
| 07/07/2004 | CN1156478C Substituted porphyrins |
| 07/07/2004 | CN1156477C Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 07/07/2004 | CN1156473C Hydrochloride of fused-heterocycle compound |
| 07/07/2004 | CN1156471C 5-phridyl-1,3-azole compounds, process for producing the same and use thereof |
| 07/07/2004 | CN1156462C Antipsychotic cyclic N-aralkyl amines |
| 07/07/2004 | CN1156461C Improved aqueous solubility pharmaceutical formulations |
| 07/07/2004 | CN1156454C Pyrimidine-2,4,6-trione metalloproteinase inhibitors |